Replies to post #219453 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Lykiri,

Thanks for posting both versions. Very difficult to miss the meaning in the short version. I certainly understand why Les would want to avoid using the word "improved" to avoid a discovery lawsuit. The word "optimized" which was used by the Germans was probably hard enough for him to swallow and as long as it is Fraunhofer's claim and not that of NWBO it keeps the wolves at bay. This also explains his distancing from this claim.
Best wishes.

[sentiment_stocks]

We will then look forward to receiving the evaluation of the clinical trial from sponsor Northwest Biotherapeutics Inc.

So for people like JR and exwannabe (yes ex, I believe my favorite bear has stated that we will never get the results for the trial over on i-village) who think the trial will never end, Fraunhofer thinks differently.

[Lykiri]

No news about the dcvax-l trial in the latest Fraunhofer IZI annual report 2018. No English version yet.

https://www.izi.fraunhofer.de/content/dam/izi/de/documents/Publikationen/Jahresbericht_IZI_2018.pdf

[flipper44]

Thanks Lykiri. Makes a lot of sense. Fits what LP stated a few years back about needing to meet rigorous manufacturing requirements in Europe. I think TFF very well might have made it into the process, and/or simply better cell selection.